Presentation is loading. Please wait.

Presentation is loading. Please wait.

Raymond U. Osarogiagbon, MBBS, Meredith A. Ray, MPH, PhD, Nicholas R

Published byΟινώνη Βενιζέλος Modified over 5 years ago

Similar presentations

Presentation on theme: "Raymond U. Osarogiagbon, MBBS, Meredith A. Ray, MPH, PhD, Nicholas R"— Presentation transcript:

1 Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria 
Raymond U. Osarogiagbon, MBBS, Meredith A. Ray, MPH, PhD, Nicholas R. Faris, MDiv, Matthew P. Smeltzer, MStat, PhD, Carrie Fehnel, BBA, Cheryl Houston-Harris, BS, CCRP, Raymond S. Signore, RNFA, Laura M. McHugh, RN, Paul Levy, MD, Lynn Wiggins, MD, Vishal Sachdev, MD, Edward T. Robbins, MD  The Annals of Thoracic Surgery  Volume 103, Issue 5, Pages (May 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 National Comprehensive Cancer Network (NCCN) lung cancer resection quality criteria attainment by year: (A) anatomic resection; (B) negative margins; (C) hilar lymph node examination; (D) examination of three or more mediastinal lymph node stations; (E) all four criteria. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Survival impact of attaining National Comprehensive Cancer Network resection quality criteria: (A) anatomic resection (anatomic, blue; no anatomic resection, red); (B) negative margins (negative margin no, blue; negative margin yes, red); (C) hilar node examination (hilar station sampled no, blue; hilar station sampled yes, red); (D) three or more mediastinal stations (mediastinal node station no, blue; mediastinal node station yes, red). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Survival impact of attaining National Comprehensive Cancer Network lung cancer resection quality criteria stratified by (A) number of criteria met (0 met, blue; 1 met, red; 2 met, green; 3 met, brown; 4 met, purple); and (B) whether all four criteria were met (all met no, blue; all met yes, red). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Raymond U. Osarogiagbon, MBBS, Meredith A. Ray, MPH, PhD, Nicholas R"

Similar presentations

Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor  Marc Riquet, MD, PhD, Antoine Legras, MD,

Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor  Marc Riquet, MD, PhD, Antoine Legras, MD,
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
True Negative Predictive Value of Endobronchial Ultrasound in Lung Cancer: Are We Being Conservative Enough?  Bryan A. Whitson, MD, PhD, Shawn S. Groth,

True Negative Predictive Value of Endobronchial Ultrasound in Lung Cancer: Are We Being Conservative Enough?  Bryan A. Whitson, MD, PhD, Shawn S. Groth,
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Chun Chieh Lin, PhD, MBA, Matthew P

Chun Chieh Lin, PhD, MBA, Matthew P
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer  Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer  Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor  Marc Riquet, MD, PhD, Antoine Legras, MD,

Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor  Marc Riquet, MD, PhD, Antoine Legras, MD,
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections  Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.

Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections  Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.
Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era

Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era
Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer  Paul J. Speicher, MD, Zachary W. Fitch,

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer  Paul J. Speicher, MD, Zachary W. Fitch,
P1.08-027 Evolution of Survival in a Regional Population-Based US Lung Cancer Resection Cohort  Raymond Osarogiagbon, Nicholas Faris, Matthew Smeltzer,

P Evolution of Survival in a Regional Population-Based US Lung Cancer Resection Cohort  Raymond Osarogiagbon, Nicholas Faris, Matthew Smeltzer,
P1.08-020 The Effect of Two Interventions on Attainment of Surgical Quality Measures in Resected Non-Small Cell Lung Cancer (NSCLC)  Nicholas Faris, Meredith.

P The Effect of Two Interventions on Attainment of Surgical Quality Measures in Resected Non-Small Cell Lung Cancer (NSCLC)  Nicholas Faris, Meredith.

Similar presentations

Ads by Google